Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -37.64% is 75% above its 5-year average of -147.77%, near the high end of its 5-year range (-409.93%–-29.33%).
4.62% above its 12-month average of -39.46%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -29.33%.
OPERATING MARGIN
-37.64%
OPERATING MARGIN AVG TTM
-39.46%
OPERATING MARGIN AVG 3Y
-51.58%
OPERATING MARGIN AVG 5Y
-147.77%
OPERATING MARGIN AVG 10Y
-1022.59%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4.62%
CURRENT VS 3Y AVG
+27.02%
CURRENT VS 5Y AVG
+74.53%
CURRENT VS 10Y AVG
+96.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
electroCore, Inc.
Market Cap
$91.15M
Operating Margin
-37.64%
TTM Avg
-39.46%
3Y Avg
-51.58%
5Y Avg
-147.77%
Market Cap
$92.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.47M
Operating Margin
0.00%
TTM Avg
-10.06%
3Y Avg
-113.57%
5Y Avg
-75.71%
Market Cap
$89.11M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
Market Cap
$87.75M
Operating Margin
7.31%
TTM Avg
8.88%
3Y Avg
-4.43%
5Y Avg
-3.84%
Market Cap
$87.48M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$95.86M
Operating Margin
-4041.72%
TTM Avg
-2020.86%
3Y Avg
-2836.09%
5Y Avg
-1938.59%
Market Cap
$96.55M
Operating Margin
-1366.43%
TTM Avg
-2706.78%
3Y Avg
-1353.39%
5Y Avg
-914.67%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $91.15M | -37.64% | -39.46% | -51.58% | -147.77% |
| Biomea Fusion, Inc. (BMEA)vs › | $92.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $89.47M | 0.00% | -10.06% | -113.57% | -75.71% |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 12.60% | -0.11% | -11.38% | -8.86% |
| Conexeu Sciences Inc. (CNXU)vs › | $88.57M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.75M | 7.31% | 8.88% | -4.43% | -3.84% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.48M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.86M | -4041.72% | -2020.86% | -2836.09% | -1938.59% |
| Korro Bio, Inc. (KRRO)vs › | $96.55M | -1366.43% | -2706.78% | -1353.39% | -914.67% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.18M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
87.1%
Operating Margin
-37.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -29.33% |
| 2026-03-31 | -55.47% |
| 2025-12-31 | -31.82% |
| 2025-09-30 | -33.19% |
| 2025-06-30 | -47.50% |
| 2025-03-31 | -56.88% |
| 2024-12-31 | -43.59% |
| 2024-09-30 | -40.45% |
| 2024-06-30 | -42.21% |
| 2024-03-31 | -70.71% |
| 2023-12-31 | -76.25% |
| 2023-09-30 | -91.53% |
| 2023-06-30 | -140.47% |
| 2023-03-31 | -222.91% |
| 2022-12-31 | -231.13% |
| 2022-09-30 | -281.17% |
| 2022-06-30 | -269.82% |
| 2022-03-31 | -293.89% |
| 2021-12-31 | -367.04% |
| 2021-09-30 | -267.99% |
| 2021-06-30 | -409.93% |
| 2021-03-31 | -447.18% |
| 2020-12-31 | -681.19% |
| 2020-09-30 | -415.29% |
| 2020-06-30 | -786.70% |
| 2020-03-31 | -1092.06% |
| 2019-12-31 | -1274.98% |
| 2019-09-30 | -1595.01% |
| 2019-06-30 | -1988.08% |
| 2019-03-31 | -3469.48% |
| 2018-12-31 | -4266.20% |
| 2018-09-30 | -8976.42% |
| 2018-06-30 | -4127.48% |
| 2018-03-31 | -11207.35% |
| 2017-12-31 | -3188.27% |
| 2017-09-30 | -2114.08% |
| 2017-06-30 | -4209.02% |
| 2017-03-31 | -4055.00% |
